The European nation reported that 23 elderly people have died within days of taking the Pfizer COVID-19 vaccine, with 13 of those deaths said to be related to “side effects”. All those who suffered supposed side effects were nursing home patients and at least 80 years old.
Ivor Cummins aka the Fat Emperor – gives James the lowdown on why you can’t trust anything our governments tell us about Covid-19. If you want the facts on Coronavirus – how deadly is it? do lockdowns and masks work? how does it compare with previous pandemics? – you’ve come to the right place
Please support the Delingpod:
Mirror archives are available below if this video is removed from YouTube.
This hunger games scenario of a middle-aged, potentially pre-infected and already immune health secretary taking a nominal, rushed, improperly trialled novel-technology vaccine after the pandemic has already passed on live TV is as unethical and obscene as any of the propaganda we have been subjected to. What have we become? If it happens, the supposed vaccinator, the TV station, the secretary of state, and the vaccine company should all be roundly condemned. It proves nothing and risks everything. Obnoxious and dangerous as he is, he hasn’t a clue what might happen to him. He is still that sacred thing: somebody’s patient. A power-crazed, ignorant man for whom the mantras “whatever it takes” and the “end justifies the means” are dear, offering himself for a macabre, televised ritual sacrifice fit for the Incas to appease his political masters. It is truly grotesque. There is no medical reason for him to have these chemicals.
- December 9 – UK authorities confirmed 2 cases of anaphylaxis after vaccination
- December 18*, 2020 – CDC has identified 6 case reports of anaphylaxis following Pfizer-BioNTech vaccine meeting Brighton Collaboration criteria for anaphylaxis
- Persons with anaphylaxis following COVID-19 vaccination should not receive additional doses of COVID-19 vaccine
Hospital pharmacists discovered Dec. 16 that some vials of Pfizer’s COVID-19 vaccines that are supposed to hold five doses actually contain six or seven, The New York Times reported.
The discovery may mean the U.S. supply of the vaccine is more robust than previously thought, but it has also caused confusion over whether to use the extra doses or throw them out, since the extra doses weren’t part of Pfizer’s guidance.
Federal officials have to carefully track the number of vaccine doses to make sure there’s enough for everyone who received an initial dose to receive a second dose three weeks later. The extra vials may complicate that effort, The Hill reported.
A hospital worker with no history of allergies was admitted to intensive care over a severe reaction she suffered 10 minutes after having Pfizer’s coronavirus vaccine. The unidentified female worker suffered an anaphylactic reaction shortly after receiving the injection at a hospital in Juneau, Alaska, on Tuesday.
Two healthcare workers in the UK suffered an anaphylactic reaction to the Pfizer injection after being given it last week, although the vaccine has been widely tested and analysed, with government experts in both the US and Great Britain deeming it safe.
More than 100,000 patients will not be able to get the Covid vaccine from their family doctor after their GP surgeries decided not to take part in its deployment, the Guardian can reveal.
The UK government has granted pharmaceutical giant Pfizer a legal indemnity protecting it from being sued, enabling its coronavirus vaccine to be rolled out across the country as early as next week.
The Department of Health and Social Care has confirmed the company has been given an indemnity protecting it from legal action as a result of any problems with the vaccine.
Ministers have also changed the law in recent weeks to give new protections to companies such as Pfizer, giving them immunity from being sued by patients in the event of any complications.
NHS staff providing the vaccine, as well as manufacturers of the drug, are also protected.
Most people will escape “severe” side effects, defined as those that prevent daily activity. Fewer than 2% of recipients of the Pfizer and Moderna vaccines developed severe fevers of 39°C to 40°C. But if the companies win regulatory approvals, they’re aiming to supply vaccine to 35 million people worldwide by the end of December. If 2% experienced severe fever, that would be 700,000 people.
Other transient side effects would likely affect even more people. The independent board that conducted the interim analysis of Moderna’s huge trial found that severe side effects included fatigue in 9.7% of participants, muscle pain in 8.9%, joint pain in 5.2%, and headache in 4.5%. In the Pfizer/BioNTech vaccine trial, the numbers were lower: Severe side effects included fatigue (3.8%) and headache (2%).
But that’s a higher rate of severe reactions than people may be accustomed to. “This is higher reactogenicity than is ordinarily seen with most flu vaccines, even the high-dose ones,” says Arnold Monto, an epidemiologist at the University of Michigan School of Public Health.
- Vaccine produced by a partnership between a University of Oxford research institute, Vaccitech, and AstraZeneca, does not need to be stored at freezing temperatures.
- Cheaper and easier to produce than the high-efficacy vaccines produced by BioNTech-Pfizer and Moderna.
- The price of AstraZeneca’s shares dropped on the news, and an analysis from an investment bank concluded, “We believe that this product will never be licensed in the US.”
- A closer look at the the Oxford-AstraZeneca trials reveals some very shaky science.
- Cherry-picked the data
- Dosing issues
- Opaque planning and data analysis procedures
- Age group selection
Two major U.S. pharmaceutical companies racing to develop novel coronavirus vaccines have announced that their vaccines have been confirmed to be over 90% effective. But Masayuki Miyasaka, a leading immunologist at Osaka University, told the Mainichi Shimbun in a recent interview that even after these vaccines become available, he does not plan to receive them for the time being.
At a meeting of the Committee on Health, Labor and Welfare of Japan’s House of Representatives on Nov. 17, Miyasaka stated, “There’s no doubt that their effectiveness is quite high, but their safety is not guaranteed at all,” sounding a word of caution about expectations for the vaccines.
Article date: Monday 6 April 2009
At stake at one point last year was more than $8bn in punitive damages being sought in a string of cases, as well as potential jail terms in Nigeria for several Pfizer staff. “There has been a complex web of cases with proceedings in Connecticut, New York, Lagos, Abuja and Kano,” Mr Etigwe said. “The strategy of big companies when they are dealing with smaller opponents is to stretch the process, to overwhelm us until we are ready to accept whatever they want to offer.” Trovan never became the blockbuster that Pfizer had hoped for and it is no longer in production. The EU has banned the drug and it has been withdrawn from sale in the US.
|Actual Study Start Date :||April 29, 2020|
|Estimated Primary Completion Date :||June 13, 2021|
|Estimated Study Completion Date :||December 11, 2022|
Dr. Mike Yeadon, former Chief Scientific Advisor, Pfizer:
- The evidence suggests that a substantial number of the positive cases are false positives.
- The government doesn’t know or is not disclosing the false positive rate.
- False positive rate may be as high as 1%, which would mean most or all of the positives are false positives.
- We are finding traces of an ‘old’ virus which can’t possibly make people sick.
- The test looks for a piece of genetic code. A positive test does not mean someone is sick.
- ONS says the prevalence of the virus is less than 0.1%.
- Pillar 2 (community) testing seems to be flawed. Method of processing samples would be inadmissible if this were a forensic case.
- The number of COVID deaths is continuing to stay low and fallen for 6 months. For it to suddenly increase would need a big change in transmission.
- Young people would have been the first who caught COVID-19 because they were not social distancing. The idea that the young people are now getting it is “for the birds.”
- If positive tests are false, they will be distributed evenly in the population. This is what we’re finding.
- Mass testing is not the answer.
- Sweden is not doing mass testing and their society has had 0.06% of their population die from COVID-19. This is the same as the UK.
- We are using a test with an undeclared false-positive rate.
- Are we re-testing the positives? This is unclear.
- A second lockdown is going to amplify the non-COVID deaths.
- UK’s lockdown was too late to prevent the initial spread.
- Mass population immunity is keeping the deaths low. This is the most reasonable explanation for the differences between the models and reality.